×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Eiger BioPharmaceuticals Files for Bankruptcy - WSJ
WSJ
The company has a deal in hand to sell its Zokinvy drug ... Shares of Eiger BioPharmaceuticals plunged to an all-time low Monday after the company...
1 month ago
Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split
PR Newswire
(Nasdaq:EIGR) (the "Company"), a commercial-stage biopharmaceutical company focused on the development of innovative therapies for rare...
3 months ago
Silicon Valley biopharmaceutical company files for Chapter 11 bankruptcy
The Mercury News
Eiger Biopharmaceuticals Inc., based in Palo Alto, filed for bankruptcy after its board of directors explored other financing options...
1 month ago
Eiger Files for Bankruptcy, Plans to Shutter Operations After Difficult Year
BioSpace
Following a series of rejections and clinical failures, Eiger BioPharmaceuticals has declared bankruptcy and will sell all its assets as the...
4 weeks ago
Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection
Yahoo Finance
Announces “Stalking Horse” Agreement for the Sale of Zokinvy® (lonafarnib) Patient Access to Zokinvy® to Continue Uninterrupted PALO ALTO,...
1 month ago
Eiger Biopharmaceuticals (EIGR) Files for Chapter 11 Bankruptcy
Bloomberg.com
Eiger Biopharmaceuticals Inc., a company developing therapies for rare metabolic diseases, has filed for bankruptcy.
1 month ago
Biotech Eiger Can Take Sentynl's Improved Drug Bid In Ch. 11
Law360
Eiger BioPharmaceuticals Inc. received approval Wednesday to select a $30 million base offer for its Zokinvy drug and use cash collateral...
4 weeks ago
Eiger BioPharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
PR Newswire
PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of...
5 months ago
Why Is Eiger BioPharmaceuticals (EIGR) Stock Down 31% Today?
InvestorPlace
Eiger BioPharmaceuticals (EIGR) stock is falling on Wednesday after the biopharmaceutical company halted a Phase 3 clinical trial.
7 months ago
Eiger ends hepatitis med's journey after liver damage reported, hunts for cash
Fierce Biotech
Eiger BioPharmaceuticals is finally putting a pin in efforts to find a home for peginterferon lambda, a drug once tried in COVID-19 that has...
7 months ago